E
Entera Bio Ltd. (ENTX)
NCM – Real vaqt narxi. Valyuta: USD
1.25
+0.08 (6.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.25
+0.08 (6.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Entera Bio Ltd., klinik bosqichdagi kompaniya, Isroilda va xalqaro miqyosda og'iz orqali yuboriladigan peptidlar va oqsilni almashtirish terapiyasini ishlab chiqish bilan shug'ullanadi. U osteoporozni davolash uchun II bosqich klinik sinovini va stressli sinishlarni davolash uchun I bosqich klinik sinovini yakunlagan og'iz orqali yuboriladigan teriparatid EB613 ni ishlab chiqadi. Kompaniya, shuningdek, gipoparatiroidizmni davolash uchun I bosqich klinik sinovida bo'lgan planshet peptidni almashtirish terapiyasi EB612; semirish, metabolik va fibrotik kasalliklarni davolash uchun I bosqich klinik sinovida bo'lgan GLP-1/glyukagonning ikkilamchi agonisti peptidi EB618; va qisqa ichak sindromi hamda shilliq qavatning yallig'lanishi va oziqa moddalarining so'rilmasligi bilan bog'liq kasalliklarni davolash uchun I bosqich klinik sinovida bo'lgan GLP-2 ni ishlab chiqishda ishtirok etadi. U LA-PTH va og'iz orqali yuboriladigan ikkilamchi agonisti GLP-1/glyukagon peptidini preklinik va klinik rivojlantirish bo'yicha OPKO Biologics, Inc. bilan hamkorlik shartnomasiga ega. Kompaniya 2009 yilda tashkil etilgan va Isroilning Quddus shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Constantin Itin Ph.D., R.Ph. | Head of Biopharmaceutics & Bioanalytics |
| Dr. Gregory Burshtein Ph.D. | Chief of Research & Development |
| Dr. Hillel Galitzer M.B.A., Ph.D. | Chief Operating Officer |
| Dr. Rachel B. Wagman | Chief Clinical Advisor |
| Ms. Cherin Smith | Executive VP & Head of Clinical Operations |
| Ms. Dana Yaacov-Garbeli CPA | Chief Financial Officer |
| Ms. Miranda J. Toledano M.B.A. | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | S-3 | zk2635174.htm |
| 2026-04-03 | 8-K | zk2634965.htm |
| 2026-03-27 | 8-K | zk2634965.htm |
| 2026-03-04 | 8-K | zk2634484.htm |
| 2026-02-09 | 8-K | zk2634303.htm |
| 2026-02-04 | 8-K | zk2634279.htm |
| 2025-11-14 | 8-K | zk2534017.htm |
| 2025-08-08 | 8-K | zk2533576.htm |
| 2025-08-08 | 10-Q | zk2533523.htm |
| 2025-07-28 | 8-K | zk2533483.htm |